搜索临床试验以:malignant rhabdoid tumor
总计34427个结果
-
Millennium Pharmaceuticals, Inc.撤销
-
GlaxoSmithKline完全的
-
AstraZenecaKuDOS Pharmaceuticals Limited完全的
-
Peking Union Medical College Hospital未知
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of Tokyo未知
-
The University of Texas Health Science Center,...未知
-
The University of Texas Health Science Center,...未知
-
Threshold PharmaceuticalsPPD完全的
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者完全的胃癌 | 食道癌 | GE Junction Cancer美国
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
AstraZeneca终止Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC芬兰
-
Asan Medical Center未知
-
Fudan UniversitySecond Affiliated Hospital, School of Medicine, Zhejiang University; Ruijin Hospital; First Affiliated... 和其他合作者未知
-
Memorial Sloan Kettering Cancer CenterRockefeller University完全的Primary or Metastatic Central Nervous System (CNS) Tumor美国